Myocardial Iron Deficiency in Hemodialysis-Dependent End-Stage Renal Disease Patients Undergoing Oral Iron Therapy.

MLA

Xu, Hua-yan, et al. “Myocardial Iron Deficiency in Hemodialysis-Dependent End-Stage Renal Disease Patients Undergoing Oral Iron Therapy.” Journal of the American College of Cardiology (JACC), vol. 70, no. 19, Nov. 2017, pp. 2455–56. EBSCOhost, https://doi.org/10.1016/j.jacc.2017.09.013.

APA

Xu, H., Yang, Z., Li, R., Shi, K., Zhang, Y., Li, Z., Xia, C., Peng, W., Chen, Q., & Guo, Y. (2017). Myocardial Iron Deficiency in Hemodialysis-Dependent End-Stage Renal Disease Patients Undergoing Oral Iron Therapy. Journal of the American College of Cardiology (JACC), 70(19), 2455–2456. https://doi.org/10.1016/j.jacc.2017.09.013

Chicago

Xu, Hua-yan, Zhi-gang Yang, Rui Li, Ke Shi, Yi Zhang, Zhen-lin Li, Chun-chao Xia, Wan-lin Peng, Qing-yong Chen, and Ying-kun Guo. 2017. “Myocardial Iron Deficiency in Hemodialysis-Dependent End-Stage Renal Disease Patients Undergoing Oral Iron Therapy.” Journal of the American College of Cardiology (JACC) 70 (19): 2455–56. doi:10.1016/j.jacc.2017.09.013.